Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
H Liu, X Zhang, Y Shao, X Lin, F Dong, X Liu - Bioengineered, 2021 - Taylor & Francis
Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …
Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
H Liu, X Zhang, Y Shao, X Lin, F Dong… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast-myofibroblast differentiation. Danshensu (DSS) has …
process is closely related to fibroblast-myofibroblast differentiation. Danshensu (DSS) has …
Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway.
H Liu, X Zhang, Y Shao, X Lin, F Dong, X Liu - Bioengineered, 2021 - europepmc.org
Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …
[引用][C] Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
H Liu, X Zhang, Y Shao, X Lin, F Dong, X Liu - Bioengineered, 2021 - cir.nii.ac.jp
Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast
transition via the MEK/ERK signaling pathway | CiNii Research CiNii 国立情報学研究所 学術 …
transition via the MEK/ERK signaling pathway | CiNii Research CiNii 国立情報学研究所 学術 …
[HTML][HTML] Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
H Liu, X Zhang, Y Shao, X Lin, F Dong, X Liu - Bioengineered, 2021 - ncbi.nlm.nih.gov
Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …